193 related articles for article (PubMed ID: 12706404)
1. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response.
Gilhar A; Landau M; Assy B; Ullmann Y; Shalaginov R; Serafimovich S; Kalish RS
Clin Immunol; 2003 Mar; 106(3):181-7. PubMed ID: 12706404
[TBL] [Abstract][Full Text] [Related]
2. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
[TBL] [Abstract][Full Text] [Related]
4. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
7. Characterization of infiltrating T cells in human scalp explants from alopecia areata to SCID nude mice: possible role of the disappearance of CD8+ T lymphocytes in the process of hair regrowth.
Tsuboi H; Tanei R; Fujimura T; Ohta Y; Katsuoka K
J Dermatol; 1999 Dec; 26(12):797-802. PubMed ID: 10659500
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-DR by anagen hair follicles in alopecia areata.
Messenger AG; Bleehen SS
J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
[TBL] [Abstract][Full Text] [Related]
12. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines.
Mcdonagh AJ; Snowden JA; Stierle C; Elliott K; Messenger AG
Br J Dermatol; 1993 Sep; 129(3):250-6. PubMed ID: 7506926
[TBL] [Abstract][Full Text] [Related]
13. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
14. The potential role of cytokines and T cells in alopecia areata.
Hoffmann R
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):235-8. PubMed ID: 10674373
[TBL] [Abstract][Full Text] [Related]
15. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
16. Type 1 interferon signature in the scalp lesions of alopecia areata.
Ghoreishi M; Martinka M; Dutz JP
Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
[TBL] [Abstract][Full Text] [Related]
17. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: A multifactorial autoimmune condition.
Simakou T; Butcher JP; Reid S; Henriquez FL
J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
[TBL] [Abstract][Full Text] [Related]
20. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.
McElwee KJ; Boggess D; King LE; Sundberg JP
J Invest Dermatol; 1998 Nov; 111(5):797-803. PubMed ID: 9804341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
